Retatrutide × Particle Peptides - Lab Test, January 2026
Test results
About this test
This independent lab test by Liquilabs confirms Retatrutide 10mg from Particle Peptides at >99.8% purity. The analysis was conducted on January 29, 2026, with batch number 2025296. The tested quantity of 10.59mg exceeds the stated label claim of 10mg.
Retatrutide is a triple GIP/GLP-1/GCG receptor agonist researched for its potential role in metabolic regulation, weight management, and glycemic control. A purity level exceeding 99.8% indicates pharmaceutical-grade synthesis with minimal impurities. Endotoxin levels tested below 0.001 EU/mg, with no detected microbial or mold contamination, confirming safety for research use.
The full certificate of analysis is available from Liquilabs.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.